Want to see HK:6826 full AI Analyst Report?
Total Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H has a market cap or net worth of HK$7.56B. The enterprise value is HK$1.36B.
Market CapHK$7.56B
Enterprise ValueHK$1.36B
Share Statistics
Shanghai Haohai Biological Technology Co., Ltd. Class H has 34,780,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,780,340
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Shanghai Haohai Biological Technology Co., Ltd. Class H’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 3.15%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)3.15%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee1.22M
Profits Per Employee122.32K
Employee Count1,999
Asset Turnover0.36
Inventory Turnover1.45
Valuation Ratios
The current PE Ratio of Shanghai Haohai Biological Technology Co., Ltd. Class H is 45.9. Shanghai Haohai Biological Technology Co., Ltd. Class H’s PEG ratio is -0.51.
PE Ratio45.9
PS Ratio2.08
PB Ratio0.94
Price to FCF11.41
Price to Operating Cash Flow13.92
PEG Ratio-0.51
Income Statement
In the last 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H had revenue of 2.45B and earned 244.51M in profits. Earnings per share was 1.08.
Revenue2.45B
Gross Profit1.69B
Operating Income221.63M
Pretax Income239.25M
Net Income244.51M
EBITDA445.99M
Earnings Per Share (EPS)1.08
Cash Flow
In the last 12 months, operating cash flow was 498.64M and capital expenditures -238.17M, giving a free cash flow of 260.48M billion.
Operating Cash Flow498.64M
Free Cash Flow260.48M
Free Cash Flow per Share7.49
Dividends & Yields
Shanghai Haohai Biological Technology Co., Ltd. Class H pays an annual dividend of HK$0.289, resulting in a dividend yield of 6.07%
Dividend Per ShareHK$0.289
Dividend Yield6.07%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-34.66%
50-Day Moving Average16.20
200-Day Moving Average19.58
Relative Strength Index (RSI)50.66
Average Volume (3m)90.95K
Important Dates
Shanghai Haohai Biological Technology Co., Ltd. Class H upcoming earnings date is Oct 24, 2026, TBA (Confirmed).
Last Earnings DateAug 21, 2026
Next Earnings DateOct 24, 2026
Ex-Dividend Date―
Financial Position
Shanghai Haohai Biological Technology Co., Ltd. Class H as a current ratio of 3.79, with Debt / Equity ratio of 8.36%
Current Ratio3.79
Quick Ratio3.21
Debt to Market Cap0.07
Net Debt to EBITDA-4.59
Interest Coverage Ratio12.05
Taxes
In the past 12 months, Shanghai Haohai Biological Technology Co., Ltd. Class H has paid 30.12M in taxes.
Income Tax30.12M
Effective Tax Rate0.13
Enterprise Valuation
Shanghai Haohai Biological Technology Co., Ltd. Class H EV to EBITDA ratio is 6.83, with an EV/FCF ratio of 6.82.
EV to Sales1.24
EV to EBITDA6.83
EV to Free Cash Flow6.82
EV to Operating Cash Flow4.84
Balance Sheet
Shanghai Haohai Biological Technology Co., Ltd. Class H has HK$2.40B in cash and marketable securities with HK$443.14M in debt, giving a net cash position of HK$1.96B billion.
Cash & Marketable SecuritiesHK$2.40B
Total DebtHK$443.14M
Net CashHK$1.96B
Net Cash Per ShareHK$56.31
Tangible Book Value Per ShareHK$21.22
Margins
Gross margin is 98.65%, with operating margin of 9.06%, and net profit margin of 10.00%.
Gross Margin98.65%
Operating Margin9.06%
Pretax Margin9.78%
Net Profit Margin10.00%
EBITDA Margin18.23%
EBIT Margin9.78%
Analyst Forecast
The average price target for Shanghai Haohai Biological Technology Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-6.45%
EPS Growth Forecast-59.23%